SEC Form 4 · accession 0001437749-26-020713
PULSE BIOSCIENCES, INC. · PLSE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maria Sainz
Director
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 8:54 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001625101
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $26.89 | Jun 11, 2026 | A | 30,000 | A | — | Jun 11, 2036 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (right to buy)F2 | $26.89 | Jun 11, 2026 | A | 3,793 | A | — | Jun 11, 2036 | Common Stock | 3,793 | 3,793 | D |
Explanation of responses
- F1The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026.
- F2The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2026.